-
Palantir drops for a second day as cult stock loses momentum
Wednesday's decline came as investors keyed in on the CEO's new stock sale plan and the possibility of defense cuts.CNBC - 4d -
The stock market closes out worst day of 2025
The stock market closed out the week with the worst day of 2025. The losses are coming amid growing concerns about economic growth. Elise Preston reports on how Americans are reacting.CBS News - 1d -
Market winners can fall hard — as investors in these favorite stocks found out
‘Magnificent Seven’ investors, take note.MarketWatch - 7h -
Dow drops 700 points for worst day of 2025 so far on new fears about economic growth
Stocks sold off on Friday as new U.S. data sparked concern among investors over a slowing economy and sticky inflation, leading them in search of safer assets.NBC News - 3d -
Block shares plunge 18%, for worst day on market in 5 years after earnings miss
Block had its worst day on the stock market since 2020 after the company reported an earnings miss.CNBC - 3d -
Do you have a favorite kid? Here's what may contribute to perception
A new study found that parental favoritism is real and that multiple factors like gender and culture could be influences.CBS News - 3d -
Walmart’s stock continues to drop despite ‘near-term buying opportunity’
Walmart Inc.’s stock deepened its losses on Friday after a brutal selloff in the previous session, as investors brushed aside positive comments from analysts.MarketWatch - 3d -
Investors call for shake-up of Europe’s ‘failed’ securitisation market
Fund managers and insurers say long-overdue reforms could unlock hundreds of billions of euros in financingFinancial Times - 3d -
Stagflation is a new threat to the stock-market rally. What investors should know.
Worries about an unwelcome mix of inflation and stagnating economic growth are back, only this time such fears are becoming harder for investors to shake off.MarketWatch - 5h
More from CNBC
-
Trump says tariffs on Canada and Mexico 'will go forward'
President Donald Trump said sweeping tariffs on Canada and Mexico "will go forward" when a monthlong delay on their implementation expires next week.CNBC - 1h -
Jamie Dimon calls U.S. government 'inefficient' and says Elon Musk's DOGE effort 'needs to be done'
In the wide-ranging interview, Dimon addressed his push to have most workers in office five days a week and his views on Ukraine, tariffs and the U.S. consumer.CNBC - 3h -
OPM undercuts Musk 'resignation' threat to federal workers
Elon Musk has been tasked by President Donald Trump with slashing federal government spending and the federal employee headcount, an effort known as DOGE.CNBC - 1h -
Anthropic closes in on $3.5 billion funding round as investor interest soars
AI startup Anthropic is in talks to raise a new round of capital that would roughly triple its valuation to $61.5 billion, CNBC has confirmed.CNBC - 1h -
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.CNBC - 21m
More in Business
-
MicroStrategy now owns $47.4 billion worth of bitcoin after latest purchases
Last week, the company disclosed that it was more than doubling its bitcoin holdings last year while reducing its workforceMarketWatch - 6m -
Only 1% of UK workers off sick find jobs within 6 months, report says
Think-tank’s findings show need to change financial incentives to help ill and disabled people return to employmentFinancial Times - 11m -
FTSE 350 on track to miss 40% target for female executives
Government-backed review says pace of change in top roles has ‘slowed’ among UK’s biggest companiesFinancial Times - 11m -
Crypto Trader OKX Pleads Guilty to Running Illegal U.S. Operation
Federal prosecutors said OKX, based in Seychelles, violated anti-money laundering laws for years. The company agreed to pay more than $500 million in fines and penalties.The New York Times - 20m -
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.CNBC - 21m